Where does Olive Healthcare Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Olive Healthcare Inc. ranks #32,730 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Olive Healthcare Inc. hold?

Olive Healthcare Inc. holds 8 US utility patents granted between 2020 and 2025, spanning 4 technology areas.

What is Olive Healthcare Inc.'s Innovation Score?

Olive Healthcare Inc. has an Innovation Score of 37.1 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Olive Healthcare Inc. focus on?

Olive Healthcare Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 2 patents. Grants appear in 4 CPC subclasses total.

Is Olive Healthcare Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Olive Healthcare Inc..

What does claim depth mean for Olive Healthcare Inc.'s patents?

Olive Healthcare Inc.'s patents average 4.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Olive Healthcare Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Olive Healthcare Inc.

USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Olive ranks #32,730 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.

#32,730
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.1/100): 4.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R32730 · Foreign Corporation #32,730 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #32,730/49,997
PHOTO-FINISH Ocuvera
CPC-NARROW A61B · 4 areas
INNOV-THIN 37.1/100
CLAIMS-SPARSE 4.1 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Ocuvera, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Olive Healthcare · this assignee

37
3D Lighting… · lowest

7

What this shows Olive's Innovation Score is 37.1/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Olive's grants concentrate

Olive Healthcare Inc. is a focused PatentsView assignee: 4 CPC subclasses with 25% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2020. By volume, Olive sits between Ocuvera, LLC and Omnis Advanced Technologies, LLC.

Olive's three-year grant acceleration

Olive Healthcare Inc. shows 6 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ocuvera

8
Oglesby Plants In…

8
Oil Lift Technolo…

8
Old Mill Brick

8
Oliver

8
Olympia Internati…

8
Omnicharge

8
Omnis Advanced

8
Olive Healthcare ◀

8

What this shows Olive holds 8 patents at rank #32,737, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Olive

By rank, the assignees closest to #32,737 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Olive's primary technology class.

Olive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Olive Healthcare Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	12.5%
2022	5	62.5%
2024	1	12.5%
2025partial year	1	12.5%

Which technologies does Olive Healthcare Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#32,730

of 49,997 tracked assignees

Innovation Score

37.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Olive Healthcare Inc.'s patent record in context - here's where to go next.

Olive Healthcare Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 25% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #32,730 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Olive Healthcare Inc. against Ocuvera, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.